Allergic sensitization and viral infections are risk factors for asthma development and progression. Sublingual vaccination with MV130, a whole heat-inactivated polybacterial preparation, protects against viral infections, but its impact on allergic sensitization and asthma development remains unknown. Here we show MV130 prevents house dust mite (HDM)-induced local type 2 immune responses and associated eosinophilic airway inflammation, conferring protection up to 9 weeks after vaccination. MV130 reduces pathophysiological and clinical asthma features in an in vivo experimental mouse model of HDM-induced allergic eosinophilic asthma, restoring normal airway functionality. MV130 impairs allergen-specific IgE sensitization and systemic type 2 inflammation endorsing type 1 and IL-10 responses. In human DCs, MV130 induces a transcriptomic and metabolic reprogramming, and restores non-pathological immune responses to allergens in healthy and asthmatic donors. Additionally, the adoptive transfer of MV130-stimulated BMDCs was sufficient to reproduce the protective features of the vaccine administration in vivo. Collectively, we show MV130 reduces allergic sensitization and eosinophilic asthma. Our findings support the exploration of mucosal interventions aimed at reducing the risk of allergen-induced asthma development.
The global rise in allergic and autoimmune diseases since the 1960s has been associated with environmental disruptions of epithelial barriers, particularly in the gastrointestinal tract. Among the implicated factors are food emulsifiers, which have become increasingly prevalent in processed foods such as peanut butter. This study investigates the biological effects of two commonly used food emulsifiers in peanut butter, soy lecithin and diacetyl tartaric acid esters of mono‐ and diglycerides (DATEM), on gastrointestinal tissue responses and immune responses using advanced in vitro gut‐on‐a‐chip models, human adult stem cell‐derived colon organoids‐on‐a‐chip, and murine models. Both emulsifiers induced dose‐dependent cytotoxicity and disrupted epithelial barriers, as demonstrated by reduced transepithelial electrical resistance and disorganization of zona occludens‐1 at daily‐exposure doses. Transcriptomic and proteomic analyses revealed activation of pro‐inflammatory pathways including TNF, NF‐κB, the unfolded protein response, and cell death by apoptosis. Soy lecithin additionally induced oxidative stress. Systemic responses were confirmed by increased pro‐inflammatory cytokines in serum and immune activation in peripheral blood mononuclear cells (PBMCs). Notably, both emulsifiers stimulated serum total IgG, soy lecithin induced IgE in mice upon feeding, and DATEM enhanced IL‐4‐induced IgE production in human PBMCs, suggesting a role in allergy development. These findings challenge the presumed safety of soy lecithin and DATEM and highlight their potential contribution to immune dysregulation and epithelial barrier dysfunction, which may initiate or exacerbate food allergy and gastrointestinal inflammatory diseases.